Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Feeding-induced muscle mTORC1 signaling regulates postprandial protein synthesis and endurance but not muscle size
Samuel C. Lapp, Krystle C. Kalafut, Madi Y. Cissé, Khaled Tighanimine, Dean M. Rosenthal, Will Doxsey, Sheng Hui, Karen E. Inouye, Claire E. Morrow, Yann Cormerais, Brendan D. Manning
Samuel C. Lapp, Krystle C. Kalafut, Madi Y. Cissé, Khaled Tighanimine, Dean M. Rosenthal, Will Doxsey, Sheng Hui, Karen E. Inouye, Claire E. Morrow, Yann Cormerais, Brendan D. Manning
View: Text | PDF
Research Article Endocrinology Muscle biology

Feeding-induced muscle mTORC1 signaling regulates postprandial protein synthesis and endurance but not muscle size

  • Text
  • PDF
Abstract

Activation of the mechanistic target of rapamycin (mTOR) complex1 (mTORC1) promotes muscle protein synthesis, mass, and function. Muscle mTORC1 can be activated by feeding and contraction. Here, muscle mTORC1 signaling, protein synthesis, mass, and function are characterized in a genetic mouse model that separates these 2 major modes of muscle mTORC1 regulation. AKT signaling is required for feeding-induced muscle mTORC1 signaling and protein synthesis, and mice expressing a mutant of tuberous sclerosis complex 2 (TSC2) that cannot be phosphorylated by AKT specifically in skeletal muscle (SkM-TSC2-5A) attenuate these effects of feeding. Despite this loss of postprandial protein synthesis, SkM-TSC2-5A mice have similar muscle and myofiber size compared with SkM-TSC2-WT mice. SkM-TSC2-5A mice maintain normal muscle mTORC1 activation in response to contraction and exhibit no differences in atrophy-related gene expression or ribosomal content. SkM-TSC2-5A mice exhibit improved maximal endurance capacity without changes in muscle contractile function. This phenotype occurs without alterations in muscle glycogen content or myofiber type, but it does coincide with a modest increase in muscle mitochondrial content. Therefore, AKT-mediated phosphorylation of TSC2 is required for postprandial mTORC1 activation and the induction of protein synthesis; however, these are dispensable for the development and maintenance of muscle mass in sedentary mice.

Authors

Samuel C. Lapp, Krystle C. Kalafut, Madi Y. Cissé, Khaled Tighanimine, Dean M. Rosenthal, Will Doxsey, Sheng Hui, Karen E. Inouye, Claire E. Morrow, Yann Cormerais, Brendan D. Manning

×

Figure 2

AKT-mediated phosphorylation of TSC2 is required for feeding-induced activation of mTORC1.

Options: View larger image (or click on image) Download as PowerPoint
AKT-mediated phosphorylation of TSC2 is required for feeding-induced act...
(A) Schematic of conditional mouse model using the Rosa26 (R26)-lox-STOP-lox-hTSC2-WT or -5A transgene knock-ins and the Tsc2fl/fl conditional allele with HSA-Cre for generation of SkM-TSC2-WT and -5A mice. (B) Ad libitum-fed 4-month-old female R26-lox-STOP-lox-hTSC2-WT or -5A; Tsc2fl/fl with or without HSA-Cre expression, as indicated. Transcript levels of the human (h)TSC2 transgene (top) and endogenous mouse (m)Tsc2 (bottom) in tibialis anterior muscle, cardiac muscle, and liver (left to right), graphed relative to WT Cre+ of the same tissue displayed (n = 1–2/group). (C–E) Immunoblots and quantifications of protein extracts from gastrocnemius and cardiac muscles of 2-month-old female SkM-TSC2-WT and -5A mice RF for 2 hours after a 16-hour overnight fast (n = 3/group). (D and E) Quantification of immunoblot data from C, with relative phospho/total protein graphed as mean ± SEM. (F–H) Immunoblots and quantification of protein extracts from gastrocnemius of 4-month-old male SkM-TSC2-WT and -5A mice fed ad libitum (n = 7–11). (G and H) Quantification of immunoblot data from F, with relative phospho/total protein graphed as mean ± SEM. (I–K) Immunoblots and quantification of protein extracts from gastrocnemius of 3-month-old male SkM-TSC2-WT and -5A mice following a 12-hour daytime fast with or without 2-hour RF, as indicated (n = 5/group). (J and K) Quantification of immunoblot data from I, with relative phospho/total protein graphed as mean ± SEM. (G and H) Mann-Whitney, (J and K) 2-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. †nonspecific band. Created in BioRender. Lapp, S. (2026) https://BioRender.com/sun06xm

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts